Abstract: A method for measuring deformation of dummy rib, includes: controlling a plurality of laser device groups to slide along corresponding curve segments respectively, and executing the following steps when the laser device groups slide to each sampling point, to obtain a degree of deformation at a position, corresponding to the sampling point, on to-be-measured dummy rib, the following steps including: controlling a laser range finder to emit a laser beam in a normal vector direction of a tangent corresponding to a position on a slide rail; determining whether the laser range finder receives corresponding reflected laser. This embodiment can have advantages of simple operation, low cost, and high accuracy.

Abstract: Anti-BAFF-R antibodies and antigen-binding fragments thereof with potentially high stability and low immunogenicity are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.

Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, an antibody variable domain or antibody construct, inter alia, useful for targeting and killing cancer cells. Due to their ability to differentially bind cancer cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.

Abstract: Chimeric antigen receptors targeting both BAFF-R and CD19 are described as are methods for their use.

Abstract: Provided herein are recombinant proteins (e.g., a bispecific antibody) capable of binding BAFF-R. The recombinant proteins (e.g., bispecific antibody) provided herein are, inter alia, useful for the treatment of cancer and autoimmune disease.

Abstract: Provided herein are BAFF-R antibodies as well as compositions and methods of making and using the same. The antibodies provided herein are, inter alia, useful for the treatment of cancer and autoimmune diseases.

Abstract: Provided herein are T cells expressing a chimeric antigen receptor (CAR) targeted to B cell activating factor receptor (BAFF-R). The CAR targeted to BAFF-R (BAFF-R CAR) described herein includes a domain that binds BAFF-R. Methods of making and using the BAFF-R CAR are also provided.

Abstract: Provided herein are T cells expressing a chimeric antigen receptor (CAR) targeted to B cell activating factor receptor (BAFF-R). The CAR targeted to BAFF-R (BAFF-R CAR) described herein includes a domain that binds BAFF-R. Methods of making and using the BAFF-R CAR are also provided.

Abstract: Provided herein are BAFF-R antibodies as well as compositions and methods of making and using the same. The antibodies provided herein are, inter alia, useful for the treatment of cancer and autoimmune diseases.

Abstract: Anti-BAFF-R antibodies and antigen-binding fragments thereof with potentially high stability and low immunogenicity are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.

Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, a chimeric antigen receptor or a bispecific antibody comprising a free immunoglobulin light chain VL, inter alia, useful for targeting and killing human mantel cell lymphoma (MCL) cells. Due to their ability to differentially bind MCL cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.

Abstract: Provided herein are recombinant proteins (e.g., a bispecific antibody) capable of binding BAFF-R. The recombinant proteins (e.g., bispecific antibody) provided herein are, inter alia, useful for the treatment of cancer and autoimmune disease.

Abstract: Provided herein are BAFF-R antibodies as well as compositions and methods of making and using the same. The antibodies provided herein are, inter alia, useful for the treatment of cancer and autoimmune diseases.

Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, an antibody variable domain or antibody construct, inter alia, useful for targeting and killing cancer cells. Due to their ability to differentially bind cancer cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.

Abstract: Provided herein are T cells expressing a chimeric antigen receptor (CAR) targeted to B cell activating factor receptor (BAFF-R). The CAR targeted to BAFF-R (BAFF-R CAR) described herein includes a domain that binds BAFF-R. Methods of making and using the BAFF-R CAR are also provided.

Abstract: Use of NADPH for preparation of a drug for antiplatelet aggregation, according to the research, it is found that in-vitro administration of exogenous NADPH inhibits ADP-induced platelet aggregation of rats in a dose-dependent mode; in-vitro administration of exogenous NADPH inhibits Thrombin-induced platelet aggregation of rats in a dose-dependent mode; preventive administration of NADPH in the rats can remarkably inhibit ADP-induced platelet aggregation; preventive administration of NADPH in the rats can remarkably inhibit Thrombin-induced platelet aggregation. Therefore, NADPH has a platelet aggregation inhibition function and can be used as a potential drug for antiplatelet aggregation.

Abstract: The use of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in preparing medicines for the treatment of heart diseases, and medicines for the treatment of heart diseases using NADPH as the active ingredient, said heart diseases including cardiac damage, myocardial infarction, and cardiomyopathy.

Abstract: An electronic device includes a touch sensitive display module. The touch sensitive display module includes a securing structure to secure a touch panel, a front frame and a display panel together. The securing structure includes an elongated securing member and double-faced adhesive tapes. The securing member includes a sidewall, and an elongated tab and an angled portion protruding from two edges of the sidewall of the securing member. The elongated tab is sandwiched between the display panel and the touch panel. The sidewall of the securing structure is sandwiched between a limiting element of the front frame and the display panel, and the limiting element of the front frame rests on the angled portion. The double-faced adhesive tape adhere the touch panel to the supporting surface of the front frame and the elongated tab, and adhere the elongated tab to the display panel.

Abstract: An electronic device includes a frame defining a slot and a through hole, a slot cover moveably received in the slot, an elastic piece rotatably connected to the frame, and a torsion spring. The elastic piece includes a main body, a side arm and an extended tab defined on opposite ends of the main body. When the elastic piece is at a normal position, the side arm faces the first through hole, and the tab faces the slot. The torsion spring includes a first arm fixed to the frame and a second arm fixed to the elastic piece. The elastic piece is rotatable by insertion of an elongated object into through the through hole to push the side arm, thereby causing the tab to push the slot cover to be deformed until the hook disengages from the slot.

Abstract: An electronic device includes a frame defining a slot and a through hole, a slot cover moveably received in the slot, an elastic piece rotatably connected to the frame, and a torsion spring. The elastic piece includes a main body, a side arm and an extended tab defined on opposite ends of the main body. When the elastic piece is at a normal position, the side arm faces the first through hole, and the tab faces the slot. The torsion spring includes a first arm fixed to the frame and a second arm fixed to the elastic piece. The elastic piece is rotatable by insertion of an elongated object into through the through hole to push the side arm, thereby causing the tab to push the slot cover to be deformed until the hook disengages from the slot.